BBH ETF
VanEck Biotech ETF
BBH ETF Overview
BBH ETF (VanEck Biotech ETF) is managed by VanEck with $515.9M in net assets. BBH expense ratio is 0.35%, holding 25 positions across sectors including Health Care, Information Technology. Inception date: 2011-12-20.
BBH performance shows a YTD return of 34.92%. The 1-year return is 42.44% and the 5-year return is 5.68%. BBH dividend yield stands at 0.37%, paid annually.
BBH top holdings include Amgen Inc. (16.5%), Gilead Sciences (14.3%), Vertex Pharmaceuticals Inc (8.3%), Regeneron Pharmaceuticals, Inc. (7.5%), Moderna Inc (6.6%). Go to all BBH holdings, BBH sectors, or BBH dividends.
BBH can be compared against other funds. Use BBH overlap to find shared positions, or BBH vs another fund for a side-by-side view. BBH alternatives are available via the screener, along with tax-loss harvesting opportunities.